The 21st Century Cures Act was recently passed by the U.S. House of Representatives by a whopping 392-26 margin and is now headed to the Senate. The stockings of every healthcare special interest and their 1,400 lobbyists will be stuffed full if this bill passes the Senate, in hopes of masking the original intent – to give the drug and medical device industries an easier, quicker path to new approvals. Merry Christmas Pharma! Find out more here. (Source: Merrill Goozner, Modern Healthcare, 12/3/16)
You are here: / / Has Christmas Come Early for Pharma?